TAP Files NDA For Prevacid Follow-On To Treat GERD-Related Illnesses

Secret of novel delivery system, trial data for TAK-390MR will be revealed at Digestive Disease Week conference in May, TAP VP-Gastrointestinal Marketing Rudolphi tells “The Pink Sheet” DAILY.”